Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Jul;68(1):253–258. doi: 10.1172/JCI110241

Impaired beta adrenergic receptor binding and function in cystic fibrosis neutrophils.

S P Galant, L Norton, J Herbst, C Wood
PMCID: PMC370792  PMID: 6265498

Abstract

Cystic fibrosis (CF), a genetic disease characterized by abnormalities of exocrine gland and mucociliary function, has recently been shown to be associated with abnormal adrenergic and cholinergic physiologic responses in addition to decreased beta adrenergic-induced cyclic AMP generation in human leukocytes. In this study we have attempted to elucidate the nature of this hyporesponsiveness by assessing beta adrenergic receptor number and affinity (KD) in the intact neutrophil using the antagonist ligand [3H] dihydroalprenolol and cyclic AMP responses to isoproterenol in addition to histamine, and prostaglandin E1 in CF subjects, CF obligate heterozygotes (CFH), and normal control subjects. CF patients had significantly less (p less than 0.025) cyclic AMP stimulation above basals levels with isoproterenol (0.1 microM to 0.1 mM), compared with control values, but no consistent differences between groups were noted with histamine or PGE1. CF neutrophils had significantly fewer (p less than 0.005) beta adrenergic receptors per neutrophil (398.0 +/- 54.2 vs. 819.4 +/- 67.2) compared with control neutrophils, but the KD (0.740 +/- 0.11 vs. 0.630 +/- 0.05 nM) did not differ significantly (p greater than 0.05). There was no correlation between clinical severity and either cyclic AMP generation or dihydroalprenolol binding (r = 0.27 and 0.24, respectively, p greater than 0.05). The CFH group had approximately 50% of the cyclic AMP stimulation compared with controls, but the number (909.8 +/- 89.3) and KD (0.710 +/- 0.09 nM) of their beta adrenergic receptors were indistinguishable from control subjects. These findings suggest "down regulation" of the beta receptor in the CF patient. The cause of this remains unknown. Although the etiology of the decreased cyclic AMP responses in CFH was not due to decreased beta adrenergic receptors as assessed by antagonist ligand binding, further studies inthe CFH group to include agonist binding, receptor-adenylate cyclase coupling, intrinsic adenylate cyclase activity, and catecholamine metabolism may help determine the basic cause of beta adrenergic hyperesposiveness in both CFH and CF.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee S. P., Kung L. S., Riggi S. J., Chanda S. K. Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature. 1977 Aug 4;268(5619):455–456. doi: 10.1038/268455a0. [DOI] [PubMed] [Google Scholar]
  2. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CHERNICK W. S., BARBERO G. J., PARKINS F. M. Studies on submaxillary saliva in cystic fibrosis. J Pediatr. 1961 Dec;59:890–898. doi: 10.1016/s0022-3476(61)80319-3. [DOI] [PubMed] [Google Scholar]
  4. Danes B. S., Bearn A. G. Oyster ciliary inhibition by cystic fibrosis culture medium. J Exp Med. 1972 Nov 1;136(5):1313–1317. doi: 10.1084/jem.136.5.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davies A. O., Lefkowitz R. J. Corticosteroid-induced differential regulation of beta-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab. 1980 Sep;51(3):599–605. doi: 10.1210/jcem-51-3-599. [DOI] [PubMed] [Google Scholar]
  6. Davis P. B., Braunstein M., Jay C. Decreased adenosine 3':5'-monophosphate response to isoproterenol in cystic fibrosis leukocytes. Pediatr Res. 1978 Jun;12(6):703–707. doi: 10.1203/00006450-197806000-00005. [DOI] [PubMed] [Google Scholar]
  7. Davis P. B., Hill S. C., Ulane M. M. Hormone-stimulated cyclic AMP production by skin fibroblasts cultured from healthy persons and patients with cystic fibrosis. Pediatr Res. 1980 Jul;14(7):863–868. doi: 10.1203/00006450-198007000-00004. [DOI] [PubMed] [Google Scholar]
  8. Davis P. B., Laundon S. C. Adenylate cyclase in leukocytes from patients with cystic fibrosis. J Lab Clin Med. 1980 Jul;96(1):75–84. [PubMed] [Google Scholar]
  9. Davis P. B., Shelhamer J. R., Kaliner M. Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis. N Engl J Med. 1980 Jun 26;302(26):1453–1456. doi: 10.1056/NEJM198006263022605. [DOI] [PubMed] [Google Scholar]
  10. Dulis B. H., Wilson I. B. The beta-adrenergic receptor of live human polymorphonuclear leukocytes. J Biol Chem. 1980 Feb 10;255(3):1043–1048. [PubMed] [Google Scholar]
  11. Galant S. P., Allred S. J. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates. J Lab Clin Med. 1980 Jul;96(1):15–23. [PubMed] [Google Scholar]
  12. Galant S. P., Duriseti L., Underwood S., Insel P. A. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med. 1978 Oct 26;299(17):933–936. doi: 10.1056/NEJM197810262991707. [DOI] [PubMed] [Google Scholar]
  13. Greenacre J. K., Conolly M. E. Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: studies in vivo. Br J Clin Pharmacol. 1978 Mar;5(3):191–197. doi: 10.1111/j.1365-2125.1978.tb01623.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hoffman B. B., Lefkowitz R. J. Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation. Annu Rev Pharmacol Toxicol. 1980;20:581–608. doi: 10.1146/annurev.pa.20.040180.003053. [DOI] [PubMed] [Google Scholar]
  15. Ignarro L. J., George W. J. Hormonal control of lysosomal enzyme release from human neutrophils: elevation of cyclic nucleotide levels by autonomic neurohormones. Proc Natl Acad Sci U S A. 1974 May;71(5):2027–2031. doi: 10.1073/pnas.71.5.2027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lefkowitz R. J., Williams L. T. Catecholamine binding to the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1977 Feb;74(2):515–519. doi: 10.1073/pnas.74.2.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mickey J., Tate R., Lefkowitz R. J. Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro. J Biol Chem. 1975 Jul 25;250(14):5727–5729. [PubMed] [Google Scholar]
  18. Mitchell I., Corey M., Woenne R., Krastins I. R., Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr. 1978 Nov;93(5):744–748. doi: 10.1016/s0022-3476(78)81070-1. [DOI] [PubMed] [Google Scholar]
  19. Roscher A. A., Schmid A. J., Hadorn B., Wiesmann U. N. Enhanced adenosine 3':5' - monophosphate response to beta-adrenergic stimulation in cystic fibrosis fibroblasts after removal of conditioned medium. Pediatr Res. 1980 Mar;14(3):261–265. doi: 10.1203/00006450-198003000-00018. [DOI] [PubMed] [Google Scholar]
  20. Rubin L. S., Barbero G. J., Chernick W. Pupillary dysfunction as a concomitant of cystic fibrosis. Pediatrics. 1966 Nov;38(5):865–873. [PubMed] [Google Scholar]
  21. SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
  22. Smith R. J., Ignarro L. J. Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling. Proc Natl Acad Sci U S A. 1975 Jan;72(1):108–112. doi: 10.1073/pnas.72.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sporn J. R., Molinoff P. B. beta-Adrenergic receptors in rat brain. J Cyclic Nucleotide Res. 1976;2(3):149–161. [PubMed] [Google Scholar]
  24. Su Y. F., Harden T. K., Perkins J. P. Isoproterenol-induced desensitization of adenylate cyclase in human astrocytoma cells. Relation of loss of hormonal responsiveness and decrement in beta-adrenergic receptors. J Biol Chem. 1979 Jan 10;254(1):38–41. [PubMed] [Google Scholar]
  25. Wanner A. Clinical aspects of mucociliary transport. Am Rev Respir Dis. 1977 Jul;116(1):73–125. doi: 10.1164/arrd.1977.116.1.73. [DOI] [PubMed] [Google Scholar]
  26. Wessels M. R., Mullikin D., Lefkowitz R. J. Differences between agonist and antagonist binding following beta-adrenergic receptor desensitization. J Biol Chem. 1978 May 25;253(10):3371–3373. [PubMed] [Google Scholar]
  27. di Sant'Agnese P. A., Davis P. B. Research in cystic fibrosis (third of three parts). N Engl J Med. 1976 Sep 9;295(11):597–602. doi: 10.1056/NEJM197609092951105. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES